The claim
“Medical treatments for pneumonia are becoming less effective due to the evolution of stronger germs.”
The claim was made by Donald Trump in a Metro.co.uk article published on 6 October 2026.
Our verdict
Unverified
We could not confirm that pneumonia treatments are getting weaker because of evolving germs. The available evidence shows resistance and treatment failures but lacks the long‑term data or causal proof needed for the claim.
Know something that settles it? Send us evidenceWhat we found
The claim combines two ideas: that treatments are becoming less effective and that this is due to stronger germs. We found sources that show high levels of antibiotic resistance in pneumonia‑causing bacteria and that a significant proportion of patients experience treatment failure. However, none of the sources provide a clear comparison of treatment success rates over time, nor do they isolate the impact of germ evolution from other factors such as vaccination, changes in diagnosis or patient health. Because the evidence does not establish a temporal trend or a direct causal link, we cannot verify the claim.
The evidence
5 of 6 sources support the claim; none contradict it.
- Background
Metro.co.uk reports Trump saying that germs have become stronger and that pneumonia treatments are less effective than before.
metro.co.uk· Trump concerned by Russia plague 'outbreak' and says microbes are 'smarter'October 6, 2026
- Supports the claim
CDC surveillance shows that over 40% of invasive pneumococcal disease cases are caused by bacteria resistant to at least one antibiotic class.
cdc.gov· Pneumococcal Disease Surveillance and TrendsFebruary 25, 2026
- Supports the claim
CDC notes that antibiotic‑resistant Streptococcus pneumoniae is a serious threat that can lead to treatment failures.
cdc.gov· Antibiotic-resistant Streptococcus pneumoniaeFebruary 24, 2026
- Supports the claim
A US insurance claims study found that about 22% of outpatient community‑acquired pneumonia patients experienced antibiotic treatment failure.
pmc.ncbi.nlm.nih.gov· Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study - PMC - Supports the claim
A Spanish retrospective cohort links antimicrobial‑resistant bacterial pneumonia to higher in‑hospital mortality and longer stays.
pmc.ncbi.nlm.nih.gov· Impact of Antimicrobial-Resistant Bacterial Pneumonia on In-Hospital Mortality and Length of Hospital Stay: A Retrospective Cohort Study in Spain - PMC - Supports the claim
CDC’s Emerging Infectious Diseases spotlight reports the emergence of antibiotic‑resistant strains such as carbapenemase‑producing Klebsiella pneumoniae in recent years.
wwwnc.cdc.gov· Pneumonia Spotlight - Emerging Infectious Diseases journal - CDCJune 1, 2026
What we could not confirm
- Long‑term data comparing pneumonia treatment success rates across different periods to show a consistent decline.
- Evidence that the observed treatment failures are due solely to the evolution of stronger germs, excluding other influences such as vaccination, diagnostic changes or patient comorbidities.
How we checked
We reviewed public health agency reports, peer‑reviewed studies and reputable news articles for information on pneumonia treatment outcomes and antibiotic resistance trends. We reviewed 10 relevant sources.
Help us check this claim
We could not find enough public evidence to confirm or refute this claim. If you know of an official record, dataset, transcript or report that settles it, send us the link. We review every submission and update this fact check when the evidence changes the picture.
Measured Take updates fact checks when new evidence emerges. Corrections are noted on the page.
All fact checks